BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 3, 2002
View Archived Issues
ARYx Raises $25M To Develop Drugs Using Retrometabolics
ARYx Therapeutics Inc. raised $25 million in a Series C round of financing - it's largest to date - and will use the funds to continue its progress as the Volvo of the drug industry. (BioWorld Today)
Read More
Centocor's Remicade Approved For Another Crohn's Indication
Read More
Plumbing Molecular Depths Of Asthma's Symptoms Turns Up 2 Culprits: Interleukin-13, STAT6
Read More
Medisyn's 'Forward Engineering' Technology Used In Cancer Effort
Read More
Holiday Notice
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Appointments And Advancements
Read More